Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs

被引:48
|
作者
Topp, Libby [1 ]
Iversen, Jenny [1 ]
Conroy, Andrew
Salmon, Allison M. [1 ]
Maher, Lisa [1 ]
机构
[1] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Viral Hepatitis Epidemiol & Prevent Program, Fac Med, Darlinghurst, NSW 2010, Australia
关键词
epidemiology; substance abuse; injections; vascular skin diseases; needle exchange programs;
D O I
10.1111/j.1753-6405.2008.00163.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To identify lifetime prevalence and predictors of self-reported injecting-related injuries and diseases (IRID) and/or injecting-related problems (IRP) among a national cross-sectional sample of injecting drug users. Methods: 1,961 clients of 45 needle and syringe programs (NSPs) who participated in the 2006 Australian NSP Survey self-completed an item regarding lifetime experience of eight separate IRIDs and IRPs. Results: Sixty-nine per cent of participants reported a history of IRID/IRP, with a mean of 1.9 injuries/problems (range 0-8). Lifetime prevalence of specific injuries/problems ranged from problems finding a vein (43%) to endocarditis (4%). Factors independently associated with IRID/IRP included bisexual identity; daily or more frequent injecting; injection of pharmaceutical preparations; female gender; longer injecting history; and hepatitis C antibody-positive serostatus. Conclusions: Consistent with existing literature, results suggest that vascular injury and localised infections are common among IDUs; and that treatment-seeking is often delayed until serious complications arise. Implications: Findings support the imperative for co-ordinated and timely treatment and prevention activities to reduce the severity and burden of these prevalent injecting outcomes.
引用
收藏
页码:34 / 37
页数:4
相关论文
共 50 条
  • [1] Injecting-related injury and disease among clients of a supervised injecting facility
    Salmon, Allison M.
    Dwyer, Robyn
    Jauncey, Marianne
    van Beek, Ingrid
    Topp, Libby
    Maher, Lisa
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2009, 101 (1-2) : 132 - 136
  • [2] Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs
    Islam, M. Mofizul
    Topp, Libby
    Iversen, Jenny
    Day, Carolyn
    Conigrave, Katherine M.
    Maher, Lisa
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2013, 37 (02) : 148 - 154
  • [3] Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs
    Ward, James
    Topp, Libby
    Iversen, Jenny
    Wand, Handan
    Akre, Snehal
    Kaldor, John
    Maher, Lisa
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2011, 35 (05) : 421 - 426
  • [4] Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997
    MacDonald, MA
    Wodak, AD
    Dolan, KA
    van Beek, I
    Cunningham, PH
    Kaldor, JM
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2000, 172 (02) : 57 - 61
  • [5] A systematic review of injecting-related injury and disease among people who inject drugs
    Larney, Sarah
    Peacock, Amy
    Mathers, Bradley M.
    Hickman, Matthew
    Degenhardt, Louisa
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : 39 - 49
  • [6] Profile and correlates of injecting-related injuries and diseases among people who inject drugs in Australia
    Colledge, Samantha
    Larney, Sarah
    Bruno, Raimondo
    Gibbs, Daisy
    Degenhardt, Louisa
    Yuen, Wing See
    Dietze, Paul
    Peacock, Amy
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2020, 216
  • [7] Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007-2015
    Jacka, Brendan
    Kemp, Robert
    Degenhardt, Louisa
    Peacock, Amy
    Clare, Philip
    Bruno, Raimondo
    Dev, Abhilash
    Sotade, Oluwadamisola
    Larance, Briony
    [J]. DRUG AND ALCOHOL REVIEW, 2019, 38 (02) : 159 - 168
  • [8] Trends in PIEDs use among male clients of needle-syringe programs in Queensland, Australia; 2007-2015
    Jacka, B.
    Peacock, A.
    Degenhardt, L.
    Bruno, R.
    Clare, P.
    Kemp, R.
    Dev, A.
    Larance, B.
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 46 : 74 - 78
  • [9] Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase
    Law, MG
    Batey, RG
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2003, 178 (05) : 197 - 198
  • [10] The economic burden to the public health system of treating non-viral injecting-related injury and disease in Australia (a cost of illness analysis)
    Sweeney, Rohan
    Conroy, Andrew B.
    Dwyer, Robyn
    Aitken, Campbell K.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2009, 33 (04) : 352 - 357